Excelsior Financial Statements From 2010 to 2024

4104 Stock  TWD 87.40  0.40  0.46%   
Excelsior Medical financial statements provide useful quarterly and yearly information to potential Excelsior Medical Co investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Excelsior Medical financial statements helps investors assess Excelsior Medical's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Excelsior Medical's valuation are summarized below:
Excelsior Medical Co does not presently have any fundamental signals for analysis.
Check Excelsior Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Excelsior Medical's main balance sheet or income statement drivers, such as , as well as many indicators such as . Excelsior financial statements analysis is a perfect complement when working with Excelsior Medical Valuation or Volatility modules.
  
This module can also supplement various Excelsior Medical Technical models . Check out the analysis of Excelsior Medical Correlation against competitors.

Excelsior Medical Co Company Current Valuation Analysis

Excelsior Medical's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Enterprise Value

 = 

Market Cap + Debt

-

Cash

More About Current Valuation | All Equity Analysis

Current Excelsior Medical Current Valuation

    
  7.28 B  
Most of Excelsior Medical's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Excelsior Medical Co is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Competition

In accordance with the recently published financial statements, Excelsior Medical Co has a Current Valuation of 7.28 B. This is 49.29% lower than that of the Health Care Providers & Services sector and 41.37% lower than that of the Health Care industry. The current valuation for all Taiwan stocks is 56.19% higher than that of the company.

Excelsior Medical Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Excelsior Medical's current stock value. Our valuation model uses many indicators to compare Excelsior Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Excelsior Medical competition to find correlations between indicators driving Excelsior Medical's intrinsic value. More Info.
Excelsior Medical Co is number one stock in return on equity category among its peers. It is rated second in return on asset category among its peers reporting about  0.29  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Excelsior Medical Co is roughly  3.42 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Excelsior Medical's earnings, one of the primary drivers of an investment's value.

About Excelsior Medical Financial Statements

Excelsior Medical investors use historical fundamental indicators, such as Excelsior Medical's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Excelsior Medical. Please read more on our technical analysis and fundamental analysis pages.
Excelsior Medical Co., Ltd. distributes medical related systems in Taiwan, China, Japan, Korea, Malaysia, and the Philippines. The company was founded in 1988 and is based in New Taipei City, Taiwan. EXCELSIOR MEDICAL operates under Medical Devices classification in Taiwan and is traded on Taiwan Stock Exchange.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Excelsior Stock Analysis

When running Excelsior Medical's price analysis, check to measure Excelsior Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Excelsior Medical is operating at the current time. Most of Excelsior Medical's value examination focuses on studying past and present price action to predict the probability of Excelsior Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Excelsior Medical's price. Additionally, you may evaluate how the addition of Excelsior Medical to your portfolios can decrease your overall portfolio volatility.